RankingsPricing
  1. US-listed companies
  2. VERTEX PHARMACEUTICALS INC
  3. Financials
  4. Stockholders' equity

VERTEX PHARMACEUTICALS INC【VRTX】

Market cap
$119.1B
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 202416,410-6.66%
Dec 31, 202317,580+26.36%
Dec 31, 202213,913+37.75%
Dec 31, 202110,100+16.27%
Dec 31, 20208,687+42.75%
Dec 31, 20196,085+37.20%
Dec 31, 20184,435+117.17%
Dec 31, 20172,042+52.62%
Dec 31, 20161,338+22.36%
Dec 31, 20151,094-0.23%
Dec 31, 20141,096-19.18%
Dec 31, 20131,356+13.43%
Dec 31, 20121,196+28.80%
Dec 31, 2011928+84.23%
Dec 31, 2010504

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)